Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human IL-15 Protein (HEK293), premium grade

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132) . IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus (es) . This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x (L) . IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

Product Specifications

Background

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132) . IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus (es) . This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x (L) . IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

Specifications

This protein carries no "tag". The protein has a calculated MW of 12.8 kDa. The protein migrates as 14-16 kDa under reducing (R) condition, and 14 kDa under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.

Accession Number

P40933-1

Expression Region

Asn 49 - Ser 162

Host

HEK293

Target

IL-15

Conjugation

Unconjugated

Tag

Native

Source

Human

Stability

-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Endotoxin

0.01 EU per μg

Purity

95%

Bioactivity

Immobilized Human IL-15, premium grade (Cat. No. IL5-H5215) at 2 μg/mL (100 μL/well) can bind Human IL-2 R beta with a linear range of 1.2-39 ng/mL (Routinely tested).

Format

Powder

Buffer

PBS, pH7.4

Additives

Trehalose

Molecular Weight

12.8 kDa

Additionnal Information

Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments

Shipping Conditions

RT

Storage Conditions

-20°C

Package Size

250ug*4

Host or Source

HEK293

Species

Human

Protein ID

P40933-1

Preservative

Trehalose

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

25-HVD3 (25-Hydroxy Vitamin D3)
SEKSM-0050-01 48 Tests

25-HVD3 (25-Hydroxy Vitamin D3)

Ask
View Details
25-HVD3 (25-Hydroxy Vitamin D3)
SEKSM-0050-02 96 Tests

25-HVD3 (25-Hydroxy Vitamin D3)

Ask
View Details
MAP2K4, phosphorylated (Ser80) (Dual Specificity Mitogen-activated Protein Kinase Kinase 4, MAP Kinase Kinase 4, MAPKK 4, MAPKK4, MKK4, JNK-activating Kinase 1, c-Jun N-terminal Kinase Kinase 1, JNKK1, JNKK, MAPK/ERK Kinase 4, MEK 4, MEK4, PRKMK4, SAPK/ERK Kinase 1, SEK1, SERK1, Stress-activated Protein Kinase Kinase 1, SAPK Kinase 1, SAPKK1, SAPKK-1, SKK1)
M2350-04K 50 µg

MAP2K4, phosphorylated (Ser80) (Dual Specificity Mitogen-activated Protein Kinase Kinase 4, MAP Kinase Kinase 4, MAPKK 4, MAPKK4, MKK4, JNK-activating Kinase 1, c-Jun N-terminal Kinase Kinase 1, JNKK1, JNKK, MAPK/ERK Kinase 4, MEK 4, MEK4, PRKMK4, SAPK/ERK Kinase 1, SEK1, SERK1, Stress-activated Protein Kinase Kinase 1, SAPK Kinase 1, SAPKK1, SAPKK-1, SKK1)

Ask
View Details
Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)
MBS1341033-01 0.02 mg (E-Coli)

Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)

Ask
View Details
Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)
MBS1341033-02 0.1 mg (E-Coli)

Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)

Ask
View Details
Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)
MBS1341033-03 0.02 mg (Yeast)

Recombinant Pseudomonas syringae pv. syringae Type III secretion protein hrcQa (hrcQa)

Ask
View Details